Scientists at Cornell University have developed a model system to test drugs against feline herpes virus 1 (FHV-1) in cats. Early results show that the antiretroviral drug raltegravir is effective against FHV-1, even when administered once daily.
A study by Cornell University researchers found genetic links between horse immune function and the papillomavirus that causes sarcoid skin tumors. The findings suggest a complex mix of virus, host genes, and tumor development, with relevance to related human conditions like cervical cancer.
Scientists at Cornell University's Baker Institute have developed a device that diagnoses stroke in under 10 minutes using a drop of blood. The technology detects biomarkers in the blood to measure the concentration of neuron-specific enolase (NSE), a substance found in higher concentrations in stroke victims.